Global Soft Tissue Allograft Market (2021-2026) by Type, Application, End-User, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global Soft Tissue Allograft Market (2021-2026) by Type, Application, End-User, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis


The Global Soft Tissue Allograft Market is estimated to be USD 5.16 Bn in 2021 and is expected to reach USD 7.34 Bn by 2026, growing at a CAGR of 7.3%.

Market Dynamics

Muscles, tendons, ligaments, nerves, and blood vessels - all are soft tissues. While they are termed soft tissues, damage to them can leave an individual in severe pain. Treatment varies from physiotherapy to replacing soft tissue. In case of surgery, doctors recommend soft tissue allografts to patients. Factors such as increasing demand for soft tissue allografts in athletics and other sports, growing cases of orthopaedics and dentistry-related with ageing and increasing focus of soft tissue allografts companies on brand protection are driving the market. Whereas high costs associated with the implementation of predictive analysis and complicated reimbursement and regulatory policies act as restraints to it.
Advancements in soft tissue replacement and untapped opportunities in emerging regions are opportunities for market growth though the presence of an ambiguous regulatory framework acts as a challenge.

Market Segmentation

The Global Soft Tissue Allograft Market is segmented further based on Type, Application, End-User and Geography.

By Type, the market is classified into Cartilage Allograft, Tendon Allograft, Meniscus Allograft, Dental Allograft and Other Type segments. Amongst all segments, the Cartilage Allograft segment is estimated to hold the highest market share during the forecast period.

By Application, the market is classified into Orthopaedic, Dentistry, Wound Care and Other Application segments. Amongst all, the Orthopaedic segment is estimated to hold the highest market share during the forecast period.

By End User, the market is classified into Hospitals, Aesthetic Centres, Orthopaedic Clinics, Dental Clinics and Other End User segments. Amongst all, the Hospitals segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. Direct Biologics, LLC, has launched AmnioWrap placental-based sheet allografts for clinical use. AmnioWrap is a unique, tri-layer graft intended for applications in acute and chronic wounds. – 12th January 2021
2. BioStem Technologies, Inc. has made the launch of AEON, the 6th and newest addition to the Company’s perinatal tissue allograft platform. – 27th October 2020

Company Profiles

Some of the companies covered in this report are Abbvie inc. (Allergan), Conmed Corporation, Xtant Medical Holdings Inc., BioStem Technologies Inc., Bone Bank Allografts, Smith & Nephew (Osiris Therapeutics Inc.), Integra Lifesciences Corporation, Stryker Corporation, etc.

IGR Competitive Quadrant

The report includes the IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

The report offers a comprehensive evaluation of the Global Soft Tissue Allograft Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
The report also contains the competitive analysis using IGR Positioning Quadrants, Infogence’s Proprietary competitive positioning tool.

Report Highlights:

A complete analysis of the market, including parent industry
Important market dynamics and trends
Market segmentation
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 IGR Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increasing Demand for Soft Tissue Allografts in Athletics and Other Sports
4.1.2 Growing Cases of Orthopaedics and Dentistry Related to Aging
4.1.3 Increasing focus of Soft Tissue Allografts Companies on Brand Protection
4.2 Restraints
4.2.1 High Cost Associated with Implementation of Predictive Analysis
4.2.2 Complicated Reimbursement and Regulatory Policies
4.3 Opportunities
4.3.1 Advancements in Soft Tissue Replacement
4.3.2 Untapped Opportunities in Emerging Regions
4.4 Challenges
4.4.1 Presence of Ambiguous Regulatory Framework
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Soft Tissue Allograft Market, By Type
6.1 Introduction
6.2 Cartilage Allograft
6.3 Tendon Allograft
6.4 Meniscus Allograft
6.5 Dental Allograft
6.6 Other Types
7 Global Soft Tissue Allograft Market, By Application
7.1 Introduction
7.2 Orthopaedic
7.3 Dentistry
7.4 Wound Care
7.5 Other Applications
8 Global Soft Tissue Allograft Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Aesthetic Centres
8.4 Orthopaedic Clinics
8.5 Dental Clinics
8.6 Other End Users
9 Global Soft Tissue Allograft Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 South America
9.3.1 Brazil
9.3.2 Argentina
9.3.3 Chile
9.3.4 Colombia
9.4 Europe
9.4.1 UK
9.4.2 France
9.4.3 Germany
9.4.4 Italy
9.4.5 Spain
9.4.6 Netherlands
9.4.7 Sweden
9.4.8 Russia
9.4.9 Rest of Europe
9.5 Asia-Pacific
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 Indonesia
9.5.5 Malaysia
9.5.6 South Korea
9.5.7 Australia
9.5.8 Sri Lanka
9.5.9 Thailand
9.5.10 Rest of APAC
9.6 Middle-East and Africa
9.6.1 Qatar
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 United Arab Emirates
10 Competitive Landscape
10.1 IGR Competitive Quadrant
10.2 Market Share Analysis
10.3 Strategic Initiatives
10.3.1 M&A and Investments
10.3.2 Partnerships and Collaborations
10.3.3 Product Developments and Improvements
11 Company Profiles
11.1 Abbvie inc. (Allergan)
11.2 Conmed Corporation
11.3 Xtant Medical Holdings Inc.
11.4 BioStem Technologies Inc.
11.5 Bone Bank Allografts
11.6 Smith & Nephew (Osiris Therapeutics Inc.)
11.7 Integra LifeSciences Corporation
11.8 Stryker Corporation
11.9 Zimmer Biomet
11.10 Arthrex Inc.
11.11 Direct Biologics
11.12 Acera Surgical, Inc
11.13 AlonSource Group
11.14 Becton, Dickinson and Company
11.15 Institut Straumann AG
11.16 Johnson & Johnson
11.17 Lattice Biologics Ltd
11.18 Medtronic PLC
11.19 MiMedx Group
11.20 Misonix, Inc
11.21 Ortho Regenerative Technologies Inc
12 Appendix
12.1 Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings